Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

Launched by BAYLOR RESEARCH INSTITUTE · Jul 17, 2013

Keywords

ClinConnect Summary

The XLPAD study is a research project aimed at understanding how effective different treatments are for patients with Peripheral Arterial Disease (PAD), a condition that affects blood flow to the legs. Specifically, the trial will compare the outcomes of patients who receive stents—small tubes placed in blood vessels to keep them open—with those who receive other types of treatments. The study will collect information from about 14,000 patients across approximately 60 sites worldwide, looking at their health and recovery over a year after their treatment. This will help doctors learn which methods work best and how they affect patients' overall health, walking ability, and any complications that may arise.

To participate in this trial, patients must have undergone a specific type of procedure to improve blood flow in arteries in their legs. However, those who had previous bypass surgery or certain other treatments will not be eligible. Patients can expect to have their progress tracked through follow-up visits at 6 and 12 months after their treatment, although these visits will be based on routine care rather than strict requirements from the study. Importantly, the study is designed to be safe for participants, as it allows their healthcare team to make treatment decisions based on what they feel is best for the patient.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Underwent Endovascular Intervention
• • Treated Superficial Femoral, Popliteal, Peroneal, Anterior Tibial, or Posterior Tibial Arteries
• Exclusion Criteria:
• • Failed Revascularization Attempt
• • Surgical Bypass
• • Only Iliac Artery Treated